Skip to main content

Table 2 Laboratory values meeting HLH diagnostic criteria found prior to, during and after trial of anakinra

From: Presentation of hemophagocytic lymphohistiocytosis due to a novel MUNC 13–4 mutation masked by partial therapeutic immunosuppression

HLH diagnostic criteria

Patient laboratory values

Timing relative to anakinra trial

Admission to prior to anakinra

During anakinra

One week after anakinra

Cytopenia in ≥ 2 cell lines

 
 

Anemia

No

Yes

No

 

Thrombocytopenia

Yes

Yes

Yes

 

Neutropenia

Yes

Yes

Yes

Fasting Hypertriglyceridemia

-

Yes

Yes

Hypofibrinogenemia

Yes

No

-

Hyperferritinemia

Yes

Yes

Yes

Elevated sCD25

-

Yes

-

NK cell activity

  
 

LU20 NK

reduced

markedly reduced

-

 

CD107a

-

Yes

-

Hemophagocytosis in bone marrow

some

-

numerous

  1. -: laboratory value not measured; NK: natural killer.